[go: up one dir, main page]

EE200400097A - Kompositsioon neurotserebrovaskulaarsete häirete ravimiseks ning meetod selles sisalduva kurkumiõlivalmistamiseks - Google Patents

Kompositsioon neurotserebrovaskulaarsete häirete ravimiseks ning meetod selles sisalduva kurkumiõlivalmistamiseks

Info

Publication number
EE200400097A
EE200400097A EEP200400097A EEP200400097A EE200400097A EE 200400097 A EE200400097 A EE 200400097A EE P200400097 A EEP200400097 A EE P200400097A EE P200400097 A EEP200400097 A EE P200400097A EE 200400097 A EE200400097 A EE 200400097A
Authority
EE
Estonia
Prior art keywords
treatment
composition
turmeric oil
neurocerebrovascular disorders
preparing turmeric
Prior art date
Application number
EEP200400097A
Other languages
English (en)
Inventor
Ray Madhur
Pal Raghwendra
Singh Satyawan
Mal Khanna Nandoo
Original Assignee
Council Of Scientific And Industrial Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Of Scientific And Industrial Research filed Critical Council Of Scientific And Industrial Research
Publication of EE200400097A publication Critical patent/EE200400097A/et
Publication of EE05374B1 publication Critical patent/EE05374B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
EEP200400097A 2001-12-14 2002-12-14 KompositsioonÁneurotserebrovaskulaarseteÁh„ireteÁravimiseksÁningÁmeetodÁsellesÁsisalduvaÁkurkumi?liÁvalmistamiseks EE05374B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34016501P 2001-12-14 2001-12-14
PCT/IB2002/005366 WO2003051380A2 (en) 2001-12-14 2002-12-14 Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders

Publications (2)

Publication Number Publication Date
EE200400097A true EE200400097A (et) 2004-10-15
EE05374B1 EE05374B1 (et) 2011-02-15

Family

ID=23332163

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200400097A EE05374B1 (et) 2001-12-14 2002-12-14 KompositsioonÁneurotserebrovaskulaarseteÁh„ireteÁravimiseksÁningÁmeetodÁsellesÁsisalduvaÁkurkumi?liÁvalmistamiseks

Country Status (19)

Country Link
US (2) US20060051438A1 (et)
EP (1) EP1453528B1 (et)
JP (1) JP4695839B2 (et)
KR (1) KR101001815B1 (et)
CN (1) CN100528149C (et)
AU (2) AU2002348802A1 (et)
BR (1) BR0214962A (et)
CA (1) CA2473874C (et)
DE (1) DE60233069D1 (et)
EA (1) EA007067B1 (et)
EE (1) EE05374B1 (et)
GE (1) GEP20084442B (et)
LT (1) LT5284B (et)
LV (1) LV13250B (et)
MX (1) MXPA04005680A (et)
NO (1) NO332066B1 (et)
UA (1) UA82057C2 (et)
WO (1) WO2003051380A2 (et)
ZA (1) ZA200404648B (et)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106492137A (zh) * 2016-12-29 2017-03-15 王明金 一种治疗抑郁症的中药组合物及其制备方法
CN106491996A (zh) * 2016-12-29 2017-03-15 王明金 一种治疗狂躁症的中药组合物及其制备方法
CN106491997A (zh) * 2016-12-29 2017-03-15 王明金 一种抗精神障碍的中药组合物及其制备方法
CN106511784A (zh) * 2016-12-29 2017-03-22 王明金 一种治疗精神疾病的中药组合物及其制备方法

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1752144A4 (en) * 2004-05-31 2007-07-11 Kaneka Corp AGENT FOR PREVENTING / IMPROVING LIFESTYLE DISEASES CONTAINING AN ESSENTIAL CURCUMA OIL COMPONENT
JPWO2006118079A1 (ja) * 2005-04-28 2008-12-18 新 山崎 皮膚の老化防止剤
US10543277B2 (en) 2005-05-30 2020-01-28 Arjuna Natural Private Limited Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
US9492402B2 (en) 2005-05-30 2016-11-15 Benny Antony Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
US8859020B2 (en) 2005-05-30 2014-10-14 Benny Antony Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone
US7883728B2 (en) 2005-05-30 2011-02-08 Arjuna Natural Extracts, Ltd. Composition to enhance the bioavailability of curcumin
US10286027B2 (en) 2005-05-30 2019-05-14 Arjuna Natural Extracts, Ltd. Sustained release formulations of curcuminoids and method of preparation thereof
DK1890546T3 (en) 2005-05-30 2019-03-11 Benny Antony Process for improving the bioavailability of curcumin
US12053438B2 (en) 2005-05-30 2024-08-06 Arjuna Natural Private Limited Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
JP4980626B2 (ja) * 2006-02-28 2012-07-18 ポーラ化成工業株式会社 プラスミノーゲンアクチベーターインヒビターｉ阻害剤及びそれを配合してなる食品組成物
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
MX2010003726A (es) * 2007-10-03 2010-09-14 Sabell Corp Composiciones herbarias y metodos de tratamiento de trastornos hepaticos.
JP2012519197A (ja) * 2009-03-05 2012-08-23 キージーン・エン・フェー Ｒ−クルクメンをベースとする植物揮発性物質
JP2013501006A (ja) 2009-07-31 2013-01-10 コグニション セラピューティクス インク． 認知機能低下の阻害剤
JP5764288B2 (ja) 2009-09-24 2015-08-19 ハウス食品グループ本社株式会社 ウコン抽出物とガジュツ抽出物とを含有する組成物
JP5578822B2 (ja) * 2009-09-25 2014-08-27 株式会社ピカソ美化学研究所 アセチルコリンエステラーゼ阻害剤
RU2013140467A (ru) 2011-02-02 2015-03-10 Когнишн Терапьютикс, Инк. Выделенные соединения из масла куркумы и способы применения
WO2012131505A1 (en) * 2011-03-29 2012-10-04 Council Of Scientific & Industrial Research Process for the modification of curcuma aromatica essential oil
GB201111319D0 (en) 2011-07-04 2011-08-17 Univ Leuven Kath Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
KR101792028B1 (ko) * 2012-01-13 2017-10-31 주식회사 엘지생활건강 피부 주름 개선 및 탄력 증진용 조성물
CN102697757B (zh) * 2012-05-18 2014-06-04 广州军区广州总医院 对羟基苄叉丙酮在制备预防和/或治疗脑病药物中的应用
JP2014201528A (ja) * 2013-04-02 2014-10-27 クラシエ製薬株式会社 抗酸化剤
EP4023294A1 (en) 2014-01-31 2022-07-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating alzheimer's disease
CN104840451B (zh) * 2014-09-23 2017-04-05 桂林八加一药业股份有限公司 一种用于治疗冠心病、高脂血症的中药有效部位、制备方法及从中分离有效成分的方法
CN105738546B (zh) * 2014-12-12 2020-01-21 桂林八加一药业股份有限公司 毛郁金药材指纹图谱的建立方法及其指纹图谱
CN105055449B (zh) * 2015-07-27 2019-08-09 中国科学院西北高原生物研究所 一种具有抗炎镇痛活性的塞隆骨提取物、制备方法及中药制剂
JPWO2018207910A1 (ja) * 2017-05-12 2020-03-12 ハウスウェルネスフーズ株式会社 抗炎症用組成物
KR102614814B1 (ko) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 신경변성 질환 치료용 조성물
US10391138B2 (en) * 2017-07-11 2019-08-27 Muniyal Ayurvedic Research Centre Multidimensional approach for Cancer treatment
CN108498755B (zh) * 2018-04-17 2021-04-09 贾洪章 治疗心脑血管疾病的中药组合物及其制备方法和用途
US12295920B2 (en) 2018-06-29 2025-05-13 House Wellness Foods Corporation Composition for treatment, prevention, or amelioration of Alzheimer's disease, a composition for suppression of brain nerve cell death, a composition for suppression of microglia activation induced by amyloid β peptide, and a composition for suppression of PGE2, TNF-α, or IL-1β production induced by amyloid βpeptide
CN111617060A (zh) * 2020-05-29 2020-09-04 广东工业大学 吉马酮的应用
CN111617059B (zh) * 2020-05-29 2023-07-25 广东工业大学 莪术二酮的应用
JP7637357B2 (ja) * 2020-09-29 2025-02-28 学校法人近畿大学 血管保護のためのターメリックオイルを含有する組成物、ならびにこのような組成物を含む飲食品および香料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83350A1 (fr) 1981-05-08 1983-03-24 Oreal Composition destinee au traitement des fibres keratiniques a base de polymere cationique et de polymere anionique a groupements vinylsulfoniques et procede de traitement la mettant en oeuvre
IN162441B (et) 1984-12-26 1988-05-28 Council Scient Ind Res
US4842859A (en) * 1986-09-08 1989-06-27 Yaguang Liu Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation
US5120538A (en) * 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
CN1100321A (zh) * 1994-03-27 1995-03-22 叶启智 灵猫香或其复方药用针剂
AU2300001A (en) * 1999-10-22 2001-05-08 Board Of Trustees Of The University Of Illinois, The Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
DE10029770A1 (de) * 2000-06-16 2001-12-20 Transmit Technologietransfer Verwendung von Curcuminen zur Behandlung von soliden Tumoren,insbesondere von Hirntumoren
JP2002030081A (ja) * 2000-07-13 2002-01-29 Shiseido Co Ltd ジアリールヘプタノイド誘導体及びマトリックスメタロプロテアーゼ活性阻害剤
KR20020073847A (ko) * 2001-03-16 2002-09-28 주식회사 바이오시너젠 쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106492137A (zh) * 2016-12-29 2017-03-15 王明金 一种治疗抑郁症的中药组合物及其制备方法
CN106491996A (zh) * 2016-12-29 2017-03-15 王明金 一种治疗狂躁症的中药组合物及其制备方法
CN106491997A (zh) * 2016-12-29 2017-03-15 王明金 一种抗精神障碍的中药组合物及其制备方法
CN106511784A (zh) * 2016-12-29 2017-03-22 王明金 一种治疗精神疾病的中药组合物及其制备方法

Also Published As

Publication number Publication date
JP4695839B2 (ja) 2011-06-08
AU2002348802A1 (en) 2003-06-30
KR101001815B1 (ko) 2010-12-15
EP1453528A2 (en) 2004-09-08
CN1615144A (zh) 2005-05-11
US20100093870A1 (en) 2010-04-15
LT5284B (lt) 2005-11-25
BR0214962A (pt) 2004-12-14
EA200400807A1 (ru) 2004-12-30
CA2473874A1 (en) 2003-06-26
NO20043000L (no) 2004-07-13
DE60233069D1 (de) 2009-09-03
NO332066B1 (no) 2012-06-18
AU2009212969B2 (en) 2011-06-02
UA82057C2 (en) 2008-03-11
LT2004060A (en) 2005-06-27
MXPA04005680A (es) 2004-10-15
EA007067B1 (ru) 2006-06-30
CA2473874C (en) 2011-11-22
US20060051438A1 (en) 2006-03-09
ZA200404648B (en) 2005-11-30
CN100528149C (zh) 2009-08-19
LV13250B (en) 2006-02-20
EE05374B1 (et) 2011-02-15
WO2003051380A2 (en) 2003-06-26
KR20040073478A (ko) 2004-08-19
WO2003051380A3 (en) 2004-06-17
GEP20084442B (en) 2008-08-10
JP2005516930A (ja) 2005-06-09
EP1453528B1 (en) 2009-07-22
AU2009212969A1 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
EE200400097A (et) Kompositsioon neurotserebrovaskulaarsete häirete ravimiseks ning meetod selles sisalduva kurkumiõlivalmistamiseks
DE50006694D1 (de) Hochtemperaturbeständiges bauteil und verfahren zur herstellung des hochtemperaturbeständigen bauteils
ITPI20030101A1 (it) Metodo ed apparato per la gestione della globalita'
IL208191A0 (en) Compositions and methods for treating rage-associated disorders
DE60143831D1 (de) Massgeschneidertes rohteil und verfahren zur herstellung des teiles
NO20011121D0 (no) FremgangsmÕte for formasjonsbehandling med deformerbare partikler
DE50213224D1 (de) Induktives bauelement und verfahren zu seiner herstellung
DE60229819D1 (de) Antriebsstrang und dessen Zusammenbaumethode
HUP0302739A3 (en) Method for the treatment of tobacco
CY2009017I2 (el) Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
FI20011403L (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
DE60201390D1 (de) Kondensatormikrofon und Verfahren zur dessen Herstellung
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
NO20040253L (no) Fremgangsmater for behandling av leverfibroser
EP1478438A4 (en) TECHNIQUES AND COMPOSITIONS FOR THE TREATMENT OF ASTHMA AND RELATED DISORDERS
FI20012328L (fi) Täyteaine pohjapaperin valmistukseen ja menetelmä pohjapaperin valmistamiseksi
PL369850A1 (en) Substituted indoles, method for production and use thereof for the inhibition of pain
AU2002363935A1 (en) Composition and method for the treatment of anorectal disorders
DE60210184D1 (de) L-cystein herstellendes Bakterium und Verfahren zur Herstellung von L-cystein
IL162053A0 (en) Method for the treatment of bone disorders
DE60239057D1 (de) Aromazusammensetzung sowie verfahren zur herstellung derselben
ATE418339T1 (de) Zusammensetzung und verfahren
NO20030717D0 (no) Forbindelser for behandling av avhengighetsforstyrrelser

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20141214